메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Pantai Hospital Kuala Lumpur at Kuala Lumpur Standard Ch…

[ 메디채널 김갑성 기자 ] From preventive screenings to Medic-On-The-Run, Pantai Hospital Kuala Lumpur brings healthcare beyond the hospital for Generation after Generation. KUALA LUMPUR, Malaysia, Oct. 7, 2025 -- Health, like running, is a journey, not a destination. As Malaysia's runners pushed their limits at the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, Pantai Hospital Kuala Lumpur (PHKL) ran with them, not just as medical support, but as a legacy partner in wellness, carrying its mission of care from one generation to the next. This year, a record-breaking 42,000 participants
- 김갑성 기자
- 2025-10-07 17:19
Milliken & Company Launches Millad ClearX™ 9000: The Clear…

Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers SPARTANBURG, S.C., Oct. 7, 2025 -- Milliken & Company proudly announces the launch of Millad ClearX™ 9000, the next generation clarifying technology for polypropylene (PP) developed to deliver ultra-clear transparency at reduced additive loading levels. Ideal for food packaging, home storage, and medical applications, Millad ClearX™ 9000 sets a new standard for value, aesthetics, and operational efficiency in transparent PP ap
- 김갑성 기자
- 2025-10-07 13:48
Kadisco General Hospital and MindHYVE.ai™ Sign Strategic M…

ADDIS ABABA, Ethiopia, Oct. 7, 2025 -- Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agentic artificial intelligence (AI), have signed a Memorandum of Understanding (MoU) to launch an ambitious collaboration that will accelerate AI-powered healthcare innovation, operational efficiency, and workforce capacity-building in Ethiopia. The partnership, formalized in Addis Ababa on September 11, 2025, brings together Kadisco's strong foundation in clinical excellence with MindHYVE.ai's™ adva
- 김갑성 기자
- 2025-10-07 13:33
Terumo Blood and Cell Technologies Honored with Corpora…

SINGAPORE, Oct. 7, 2025 -- Terumo Blood and Cell Technologies (Terumo BCT) has been recognized with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2025 Regional Edition organized by Enterprise Asia, a testament to its unwavering commitment to innovation, patient care, and global healthcare advancement. Serving customers in more than 160 countries, Terumo BCT empowers blood and cell-based therapies that improve patient outcomes and address unmet medical needs. With 7,900 associates and over 400 distributors, the company maintains a strong global presence spa
- 김갑성 기자
- 2025-10-07 13:25
Japanese Innovation Comes to Thailand: Revolutionary My…

TOKYO, Oct. 7, 2025 -- Leading Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduce Thailand to its groundbreaking myopia management device, Kubota Glass, at Bangkok. Addressing Thailand's Growing Myopia Crisis Thailand is facing a growing myopia challenge, with studies reporting that over 60%* of young adults are already myopic—among the highest rates observed in Southeast Asia. This pattern reflects the wider regional concern, where nearly half of the world's population is projected to be myopic by 2050. "Thai families are
- 김갑성 기자
- 2025-10-07 11:00
Revolutionary Myopia Management Technology Expands A…

TOKYO, Oct. 7, 2025 -- Kubota Pharmaceutical Holdings Co., Ltd. (TSE: 4596) today announced that its groundbreaking myopia management device, Kubota Glass, will make its international debut at ASEAN International Optics Fair Bangkok 2025, taking place in Bangkok, Thailand, from October 9-11, 2025. Addressing Asia's Myopia Crisis With half of the world's population projected to become myopic by 2050, childhood myopia progression has emerged as a critical public health challenge, particularly across Asia where prevalence rates are among the highest globally. Current treatm
- 김갑성 기자
- 2025-10-07 10:00
Chula's "Smart Salt" Wins Gold for Cutting Sodium Without Losing…

BANGKOK, Oct. 7, 2025 -- "Smart Salt," an innovative low-sodium salt developed by Paul Patsapong Chomchey, a Ph.D. candidate at Chulalongkorn University and Executive MBA alumnus, has won a Gold Medal and Special Award at the 2025 Silicon Valley International Invention Festival. Using Nano Chitosan technology, Smart Salt cuts sodium by more than half while preserving full flavor, offering a breakthrough solution to the global health challenge of excessive salt consumption. Paul Patsapong Chomchey, a graduate of Chulalongkorn University's Executive MBA Program, Class
- 김갑성 기자
- 2025-10-07 09:00
UEG Week 2025: Microplastics found to change gut microbiom…

BERLIN, Oct. 7, 2025 -- New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer. This study, conducted within the framework of microONE, a pioneering COMET Module programme project led by CBmed research center in collaboration with international partners, is among the first to directly examine how different types of microplastics interact with the human gut microbiome. As part of micr
- 김갑성 기자
- 2025-10-07 06:01
UEG 위크 2025: 최초의 인간 샘플 연구에서 미세플라스틱 노출에 따른 장내 미생물 구성…

베를린, 2025년 10월 7일 -- 우리 주변 환경에서 흔히 발견되는 5mm 미만의 플라스틱 입자인 미세플라스틱이 인간의 장내 미생물(gut microbiome)을 변화시킬 수 있고, 일부 변화는 우울증 및 대장암에서 나타나는 변화 패턴과 유사한 것으로 UEG 위크 2025(UEG Week 2025)에서 6일 발표된 새로운 연구결과를 통해 확인됐다. 씨비메드(CBmed) 연구 센터가 국제 파트너들과 협력해 주도한 선구적인 코밋(COMET) 모듈 프로그램의 일환으로 진행된 마이크로원(microONE) 프로젝트에서 수행된 본 연구는 다양한 유형의 미세플라스틱이 인간 장내 미생물과 어떻게 상호작용하는지 직접 조사한 최초의 연구에 속한다. 인체 내에서 미세 및 나노 플라스틱 입자의 영향을 탐구하겠다는 마이크로원의 광범위한 사명의 일환으로 추진된 이번 연구는 미세플라스틱이 건강에 미칠 수 있는 잠재적 영향에 대한 중요한 새로운 통찰을 제공해주는 동시에 추가 연구의 필요성이 시급함을 확인시켜준다. 연구진은 건강한 자원자 5명의 대변 샘플을 이용해 체외(ex vivo) 장내 미생물 배양을 수행했다. 이어 배양체를 폴리스티렌, 폴리프로필렌,
- 김갑성 기자
- 2025-10-07 06:01
MPF Powers a Mission-Critical Rebuild of Bridge2Practise: From…

SYDNEY, Oct. 7, 2025 -- Miroma Project Factory (MPF) has partnered with the University of Sydney to deliver a high-stakes, deeply technical modernisation of Bridge2Practise—a clinical skills training platform used by medical students and educators to simulate and assess procedural learning. Behind the scenes, Bridge2Practise was running on a five-year-old version of MeteorJS, linked to a deprecated database platform, with manual deployments, missing infrastructure documentation, and broken user flows. A growing backlog of bugs, performance issues, and unfulfilled feature reques
- 김갑성 기자
- 2025-10-07 05:07

이전

81 82 83 84 85 86 87 88 89 90

많이 본 기사

최근기사

2025-12-16_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 16일 15시 50분